当前位置:首页 - 行情中心 - 海特生物(300683) - 财务分析 - 现金流量表

海特生物

(300683)

  

流通市值:42.15亿  总市值:45.20亿
流通股本:1.22亿   总股本:1.31亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金113,179,980.17503,810,380.48372,277,047.5253,376,022.67
  收到的税费返还50,436.21139,833.2130,782.37131,844.06
  收到其他与经营活动有关的现金12,024,503.1127,292,446.320,121,993.439,604,969.81
  经营活动现金流入小计125,254,919.49531,242,659.98392,529,823.3263,112,836.54
  购买商品、接受劳务支付的现金39,149,683.02167,070,193.01119,501,849.0579,396,886.34
  支付给职工以及为职工支付的现金51,931,007.84241,653,525.31199,457,004.73138,775,375.39
  支付的各项税费7,483,458.2423,619,536.3918,997,071.7815,883,844.75
  支付其他与经营活动有关的现金29,202,743.57175,437,382.05130,614,231.4287,129,414.72
  经营活动现金流出小计127,766,892.67607,780,636.76468,570,156.98321,185,521.2
  经营活动产生的现金流量净额-2,511,973.18-76,537,976.78-76,040,333.68-58,072,684.66
二、投资活动产生的现金流量:
  收回投资收到的现金278,115,903.571,635,396,794.52904,650,000469,927,870.64
  取得投资收益收到的现金1,584,382.112,848,345.094,097,617.373,616,716.38
  处置固定资产、无形资产和其他长期资产收回的现金净额483,7001,369,673.51473,473.5149,000
  投资活动现金流入小计280,183,985.671,649,614,813.12909,221,090.88473,593,587.02
  购建固定资产、无形资产和其他长期资产支付的现金11,928,736.7150,535,918.5747,579,526.3429,731,962.99
  投资支付的现金646,503,455.51,265,187,978.38973,800,000531,184,452.46
  支付其他与投资活动有关的现金-971,643.539,759,621.88185,536.49
  投资活动现金流出小计658,432,192.211,316,695,540.451,061,139,148.22561,101,951.94
  投资活动产生的现金流量净额-378,248,206.54332,919,272.67-151,918,057.34-87,508,364.92
三、筹资活动产生的现金流量:
  吸收投资收到的现金-4,000,0004,000,0004,000,000
  其中:子公司吸收少数股东投资收到的现金-4,000,000--
  筹资活动现金流入平衡项目-000
  筹资活动现金流入小计-4,000,0004,000,0004,000,000
  偿还债务支付的现金1,003,139.424,964,789.884,075,491.533,254,618.66
  分配股利、利润或偿付利息支付的现金-17,869,627.7117,691,935.3917,436,607.39
  支付其他与筹资活动有关的现金4,170,431.048,421,5053,861,732.661,306,636.33
  筹资活动现金流出小计5,173,570.4631,255,922.5925,629,159.5821,997,862.38
  筹资活动产生的现金流量净额-5,173,570.46-27,255,922.59-21,629,159.58-17,997,862.38
四、汇率变动对现金及现金等价物的影响-14,826.84-3,164.261,699.94737.53
五、现金及现金等价物净增加额-385,948,577.02229,122,209.04-249,585,850.66-163,578,174.43
  加:期初现金及现金等价物余额648,242,569.6419,120,360.56419,120,360.56419,120,360.56
  期末现金及现金等价物余额262,293,992.58648,242,569.6169,534,509.9255,542,186.13
补充资料:
  净利润--235,430,201.19--40,202,379.5
  资产减值准备-124,202,306.5-6,804,040.36
  固定资产和投资性房地产折旧-68,204,958.96-31,349,225.57
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-68,204,958.96-31,349,225.57
  无形资产摊销-25,565,530-11,859,259.14
  长期待摊费用摊销-2,490,095.9-1,923,408.32
  处置固定资产、无形资产和其他长期资产的损失-979,179.5-572.48
  固定资产报废损失-233,444.38-69,202.92
  公允价值变动损失-12,521,343.58--5,136,870.6
  财务费用-1,390,342.84-748,297.18
  投资损失--20,643,544.25--12,692,210.67
  递延所得税--3,965,614.84--1,780,670.71
  其中:递延所得税资产减少--582,897.47--1,567,778.62
    递延所得税负债增加--3,382,717.37--212,892.09
  存货的减少-12,378,341.24-7,259,266.72
  经营性应收项目的减少--8,709,997.93--5,508,690.91
  经营性应付项目的增加--59,329,889.96--54,639,432.6
  现金的期末余额-648,242,569.6-255,542,186.13
  减:现金的期初余额-419,120,360.56-419,120,360.56
  现金及现金等价物的净增加额-229,122,209.04--163,578,174.43
公告日期2026-04-242026-04-242025-10-232025-08-26
审计意见(境内)标准无保留意见
TOP↑